Insmed Incorporated
INSM
Rankning i aktier
#1111
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Aktiekurs
$94.04
Marknadsvärde
$20.54B
Förändring (1 dag)
-0.01%
Förändring (1 år)
-41.37%
Land
US
Handel Insmed Incorporated (INSM)
Kategori
Healthcare
Aktiekurshistorik för Insmed Incorporated (INSM)
Högsta slutkurs: $99.95 den 2026-10-01
Lägsta slutkurs: $139.94 den 2000-06-01
Lägsta slutkurs: $139.94 den 2000-06-01
Aktiekurshistorik för Insmed Incorporated från 2000 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -25.98% |
| 2025 | 163.90% |
| 2024 | 150.02% |
| 2023 | 48.62% |
| 2022 | -29.22% |
| 2021 | -27.29% |
| 2020 | 59.86% |
| 2019 | 62.30% |
| 2018 | -51.70% |
| 2017 | 128.88% |
| 2016 | -24.86% |
| 2015 | 16.87% |
| 2014 | -8.76% |
| 2013 | 145.55% |
| 2012 | 112.00% |
| 2011 | -49.13% |
| 2010 | -19.73% |
| 2009 | 46.16% |
| 2008 | -42.34% |
| 2007 | -13.04% |
| 2006 | -35.82% |
| 2005 | -15.49% |
| 2004 | -33.15% |
| 2003 | 447.28% |
| 2002 | -85.64% |
| 2001 | 16.21% |
| 2000 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $536.98 | 25.92% |
US
|
|
| $224.77 | 737.11% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $876.75 | 7.69% |
NL
|
